Abstract
Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with severe acute COVID-19.
Keywords: COVID-19; SARS-CoV-2; bradycardia; pediatrics; remdesivir.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, remdesivir., pediatrics, bradycardia, 【초록키워드】 Treatment, coronavirus disease, Coronavirus disease 2019, coronavirus, therapy, pediatric, Remdesivir, severe acute respiratory syndrome Coronavirus, Severe acute respiratory syndrome, pediatrics, adverse event, Patient, bradycardia, sinus bradycardia, acute respiratory syndrome, Side effect, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, acute COVID-19, MOST, RNA polymerase inhibitor, reported, the patient, treated, spreads, 【제목키워드】 review, literature, report, Sinus,
【저자키워드】 COVID-19, SARS-CoV-2, remdesivir., pediatrics, bradycardia, 【초록키워드】 Treatment, coronavirus disease, Coronavirus disease 2019, coronavirus, therapy, pediatric, Remdesivir, severe acute respiratory syndrome Coronavirus, Severe acute respiratory syndrome, pediatrics, adverse event, Patient, bradycardia, sinus bradycardia, acute respiratory syndrome, Side effect, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, acute COVID-19, MOST, RNA polymerase inhibitor, reported, the patient, treated, spreads, 【제목키워드】 review, literature, report, Sinus,
{{{ 추상적인 }}}
렘데시비르는 2019년 중증 급성 코로나바이러스 감염증(COVID-19) 환자의 치료에 일반적으로 사용되는 RNA 중합효소 억제제입니다. 중증급성호흡기증후군 코로나바이러스 2가 확산되면서 렘데시비르의 사용이 늘어날 가능성이 있다. 일부 부작용이 보고되었지만 렘데시비르로 치료받은 대부분의 환자는 어떠한 부작용도 경험하지 않습니다. 여기에서는 중증 급성 COVID-19 소아 환자에서 렘데시비르 치료와 관련된 동서맥 1례를 설명합니다.
{{ 키워드: }} 코로나19; 사스 코로나바이러스 2; 서맥; 소아과; 렘데시비르.